---
title: "What is Regadenoson?"
---
Regadenoson (lexiscan) is the 1st selective A2A receptor agonist that is approved by the FDA and is currently used clinically. It has many of the characteristics of an ideal stress perfusion agent, being a potent and a selective coronary vasodilator with a rapid onset of action, a short duration of action, and being administered as a &#64257;xed-dose bolus (not weight-based).

